Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Neumann

Showing results (21-30 of 118) with videos related to

Pageof 12
Sort By:
Evolutionary Computation|February 21, 2015
A Parameterised Complexity Analysis of Bi-level Optimisation with Evolutionary AlgorithmsDogan Corus, Per Kristian Lehre, Frank Neumann, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 18, 2024
Multiplexed Immunophenotyping of Lymphoma Tissue SamplesChristina Schniederjohann, Peter-Martin Bruch, Sascha Dietrich, et al.
Evolutionary Computation|December 4, 2025
Runtime Analysis of Evolutionary Diversity Optimization on the Multi-objective (LeadingOnes, TrailingZeros) ProblemDenis Antipov, Aneta Neumann, Frank Neumann, et al.
International Journal of Cancer|July 9, 2005
B-cell epitopes from the cancer testis antigen NY-ESO-1Klaus-Dieter Preuss, Evi Regitz, Frank Neumann, et al.
Evolutionary Computation|November 27, 2018
Automated Algorithm Selection: Survey and PerspectivesPascal Kerschke, Holger H Hoos, Frank Neumann, et al.
Evolutionary Computation|June 30, 2010
Approximating covering problems by randomized search heuristics using multi-objective modelsTobias Friedrich, Jun He, Nils Hebbinghaus, et al.
Evolutionary Computation|February 12, 2009
Analyses of simple hybrid algorithms for the vertex cover problemTobias Friedrich, Jun He, Nils Hebbinghaus, et al.
Immunological Reviews|November 26, 2002
Analysis of the B-cell repertoire against antigens expressed by human neoplasmsKlaus-Dieter Preuss, Carsten Zwick, Claudia Bormann, et al.
Leukemia Research|July 22, 2008
Levels of beta 2 microglobulin have a prognostic relevance for patients with myelodysplastic syndrome with regard to survival and the risk of transformation into acute myelogenous leukemiaFrank Neumann, Norbert Gattermann, Hans-Ulrich Barthelmes, et al.
Blood Advances|June 11, 2024
T-cell malignancies with anti-CD19 chimeric antigen receptor T-cell therapyLisa J Martin, James B Whitmore, Rhine R Shen, et al.
Pageof 12

Showing results (21-30 of 118) with videos related to

Sort By:
Pageof 12
Evolutionary Computation|February 21, 2015
A Parameterised Complexity Analysis of Bi-level Optimisation with Evolutionary AlgorithmsDogan Corus, Per Kristian Lehre, Frank Neumann, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 18, 2024
Multiplexed Immunophenotyping of Lymphoma Tissue SamplesChristina Schniederjohann, Peter-Martin Bruch, Sascha Dietrich, et al.
Evolutionary Computation|December 4, 2025
Runtime Analysis of Evolutionary Diversity Optimization on the Multi-objective (LeadingOnes, TrailingZeros) ProblemDenis Antipov, Aneta Neumann, Frank Neumann, et al.
International Journal of Cancer|July 9, 2005
B-cell epitopes from the cancer testis antigen NY-ESO-1Klaus-Dieter Preuss, Evi Regitz, Frank Neumann, et al.
Evolutionary Computation|November 27, 2018
Automated Algorithm Selection: Survey and PerspectivesPascal Kerschke, Holger H Hoos, Frank Neumann, et al.
Evolutionary Computation|June 30, 2010
Approximating covering problems by randomized search heuristics using multi-objective modelsTobias Friedrich, Jun He, Nils Hebbinghaus, et al.
Evolutionary Computation|February 12, 2009
Analyses of simple hybrid algorithms for the vertex cover problemTobias Friedrich, Jun He, Nils Hebbinghaus, et al.
Immunological Reviews|November 26, 2002
Analysis of the B-cell repertoire against antigens expressed by human neoplasmsKlaus-Dieter Preuss, Carsten Zwick, Claudia Bormann, et al.
Leukemia Research|July 22, 2008
Levels of beta 2 microglobulin have a prognostic relevance for patients with myelodysplastic syndrome with regard to survival and the risk of transformation into acute myelogenous leukemiaFrank Neumann, Norbert Gattermann, Hans-Ulrich Barthelmes, et al.
Blood Advances|June 11, 2024
T-cell malignancies with anti-CD19 chimeric antigen receptor T-cell therapyLisa J Martin, James B Whitmore, Rhine R Shen, et al.
Pageof 12